-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Susan Raspa, RN, BSN

Articles by Susan Raspa, RN, BSN

The Evolution of Prostacyclins in Pulmonary Arterial Hypertension: From Classical Treatment to Modern Management

ByCharles D. Burger, MD, FCCP,Lesley D'Albini, PharmD, BCPS,Susan Raspa, RN, BSN,Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC

January 15th 2016

Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?

ByGeorge Ruiz, MD, MBA,Gary M. Besinque, PharmD,Cassandra A. Lickert, MD,Susan Raspa, RN, BSN

July 9th 2015

Participating Faculty: Combination Therapy in Pulmonary Arterial Hypertension: Is This the New Standard of Care?

ByGeorge Ruiz, MD, MBA,Gary M. Besinque, PharmD,Cassandra A. Lickert, MD,Susan Raspa, RN, BSN

July 8th 2015

Participating Faculty: Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era

ByStacy A. Mandras, MD,Robert J. Gilkin, Jr, RPh, MBA,Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC,Susan Raspa, RN, BSN

October 26th 2014

Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era

ByStacy A. Mandras, MD,Robert J. Gilkin, Jr, RPh, MBA,Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC,Susan Raspa, RN, BSN

October 24th 2014

Latest Updated Articles

Trending on AJMC

Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Social Factors May Match, Outpace Genetic Risk in Disease Prediction

Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC